Survodutide Prices
Also known as BI 456906; GLP-1/GCG receptor agonist
15 listings from 10 vendors, normalised to one honest price per milligram.
Cheapest per mg
$1.50/mg
At
Andy Peps Studio (APS)
Vendors
10
Sizes
2mg Kit (10 vials), 4mg Kit (10 vials), 5mg Kit (10 vials), 6mg, 10mg Kit (10 vials), 10mg, 12mg, 20mg
Disclosure. Some vendors below are Peptul partners and pay us a commission when you buy through our link. Rows here are ordered by price per milligram only - paying us never moves a vendor up. Current discount codes are shown on the full price board.
Survodutide price per mg by vendor
Prices last collected August 19, 2026.
| Vendor | Size | Price | Per mg | |
|---|---|---|---|---|
| Andy Peps Studio (APS)Verified COA | 5mg Kit (10 vials) | $75.00 | $1.50 | View |
| Andy Peps Studio (APS)Verified COA | 4mg Kit (10 vials) | $65.00 | $1.63 | View |
| BeiBangAnVerified COA | 10mg Kit (10 vials) | $170.00 | $1.70 | View |
| Huatai PeptideVerified COA | 10mg Kit (10 vials) | $286.00 | $2.86 | View |
| Huatai PeptideVerified COA | 5mg Kit (10 vials) | $143.00 | $2.86 | View |
| Hybiopeptides (HYB Peptides)Verified COA | 10mg Kit (10 vials) | $315.00 | $3.15 | View |
| Hybiopeptides (HYB Peptides)Verified COA | 5mg Kit (10 vials) | $195.00 | $3.90 | View |
| Hybiopeptides (HYB Peptides)Verified COA | 2mg Kit (10 vials) | $135.00 | $6.75 | View |
| EZ PeptidesVerified COAShips US | 10mg | $78.00 | $7.80 | View |
| PeptidologyVerified COAShips US | 10mg | $79.99 | $8.00 | View |
| Umbrella LabsVerified COAShips US | 20mg | $199.99 | $10.00 | View |
| Protide HealthVerified COAShips US | 10mg | $110.00 | $11.00 | View |
| Xcel PeptidesVerified COAShips US | 12mg | $149.00 | $12.42 | View |
| Umbrella LabsVerified COAShips US | 10mg | $129.99 | $13.00 | View |
| Paramount PeptidesVerified COAShips US | 6mg | $225.00 | $37.50 | View |
About Survodutide
- What it is
- Survodutide is an investigational once-weekly injectable peptide that activates both the glucagon receptor and the glucagon-like peptide-1 receptor. It is being studied in late-stage clinical trials for chronic weight management in obesity and for metabolic dysfunction-associated steatohepatitis, and it has also been evaluated in type 2 diabetes. It is not approved by any regulatory agency.
- How it works
- It activates both the glucagon and GLP-1 receptors, an action linked to reduced appetite and increased energy expenditure.
- Researched for
- Obesity; weight management; liver disease; type 2 diabetes
- Half-life
- Not established in humans
- Familiarity
- Intermediate
- Research evidence
- Human trials - phase 2 or 3
- Regulatory status
- Phase 3
- Key risk
- None documented
For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.